PCSS-O Free Online Module!

Prescribers’ Clinical Support System for Opioid Therapies (PCSS-O) is a three year grant funded by Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT). It is a collaborative project led by American Academy of Addiction Psychiatry (AAAP) with: American Dental Association (ADA), American Medical Association (AMA), American Osteopathic Academy of Addiction Medicine (AOAAM), American Psychiatric Association (APA), American Society for Pain Management Nursing (ASPMN), and International Nurses Society on Addictions (IntNSA). These organizations are providing training and education on the safe and effective prescribing of opioid medications in the treatment of pain and/or opioid addiction.
Free Online Module!
By Ward Hagar, MD Director, Adult Sickle Cell Center Children's Hospital & Research Center Oakland Oakland, California
Module Description: Sickle Cell patients have severe and recurrent pains as their major quality of life issue. The pains form unique pain syndromes that draw little from other models of acute and chronic pains. Many providers, although recognizing the devastation of these pains, are understandable concerned about using opioids (often in high dosages.) Providers want to make sure that they are helping the patients in both the short and long terms with their pains, pain plains, and pain controls. The PCSS-O's module on Opioids Use in Sickle Cell Pain will give providers with solid bases in the skills, knowledge, and attitudes that will allow physicians to treat most patients with Sickle Cell pains, and how to identify and to approach the small percentage of more challenging pain patients.

Funding for this initiative was made possible (in part) by Prescribers’ Clinical Support System for Opioid Therapies (1H79TI023439) from SAMHSA.The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the officialpolicies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.